| Corporate Name |
- |
OncoTherapy Science, Inc. |
| Head Office |
- |
Kanagawa Science Park R&D D11F,
3-2-1 Sakado, Takatsu-ku, Kawasaki City, Kanagawa,213-0012 Japan
(MAP)
TEL: +81-44-820-8251,
FAX: +81-44-820-8252 |
| Foundation |
- |
April 6, 2001 |
| Paid-in Capital |
- |
3.50 billion JPY |
| Accounting Term |
- |
Every March |
| Board Members |
- |
| Kensuke Tomita |
Chairman of the Board of Directors |
| Takuya Tsunoda,M.D.,Ph.D. |
President and CEO |
| Kazuo Yamamoto |
Director |
| Hiroshi Yamaji |
Director |
| Toyomasa Katagiri,Ph.D |
Outside Director |
| Shuichi Nakatsuru,Ph.D |
Auditor |
| Miyako Takagi |
Outside Auditor |
| Yuichi Komine |
Outside Auditor |
|
| Number of Employees |
- |
85 (As of March.2010)
|
Subsidiary
| Immunas Pharma, Inc. (Former: OMab Pharma, Inc.) |
| Business Outline |
- |
Development of Anti-cancer Antibody Medicines. |
| Head Office |
- |
Kanagawa Science Park R&D D11F, 3-2-1 Sakado, Takatsu-ku, Kawasaki City, Kanagawa, 213-0012 Japan |
| |
|
|
| Laboratoires OncoTherapy Science France S.A.R.L. |
| Business Outline |
- |
Research and development of Anti-cancer including Antibody Medicines. |
| Head Office |
- |
Lyon FRANCE |
| |
|
|
Affiliate Company
| Mirai Iryo Research Center, Inc. |
| Business Outline |
- |
Provision of Services for Clinical Research or Trials. |
| Head Office |
- |
6-8, Kouji-machi 4, Chiyoda-ku, Tokyo, 102-0083 Japan |
|
